Prevalence and determinants of coronary artery disease in males and females with familial combined hyperlipidaemia

Atherosclerosis

Volumn 199, Issue 2, 2008, Pages 402-407

  Pitsavos, Christos ^a   Skoumas, Ioannis ^a   Masoura, Constantina ^a   Aznaouridis, Konstantinos ^a   Papadimitriou, Lambros ^a   Chrysohoou, Christina ^a   Giotsas, Nikolaos ^a   Toutouza, Marina ^a   Stefanadis, Christodoulos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Coronary artery disease; Familial combined hyperlipidaemia; Gender; Risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DYSLIPIDEMIA; EXERCISE TEST; FAMILIAL COMBINED HYPERLIPIDAEMIA; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; MALE; ODDS RATIO; PREVALENCE; REGRESSION ANALYSIS; RISK; RISK FACTORS; SEX FACTORS;

EID: 47649121543     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.11.021     Document Type: Article

References (33)

1. Voors-Pette C., and de Bruin T.W. Excess coronary heart disease in familial combined hyperlipidemia, in relation to genetic factors and central obesity. Atherosclerosis 157 (2001) 481-489
2. Naukkarinen J., Ehnholma C., and Peltonen L. Genetics of familial combined hyperlipidemia. Curr Opin Lipidol 17 (2006) 285-290
3. Veerkamp M., de Graaf J., Bredie S., et al. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study. Arterioscler Thromb Vasc Biol 22 (2002) 274-282
4. Shoulders C.C., Johnes E.L., and Naoumona R.P. Genetics of familial combined hyperlipidemia and risk of coronary heart disease. Hum Mol Genet 13 (2004) 149-160
5. de Graaf J., Veerkamp M., and Stalenhoef A. Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids. J R Soc Med 95 Suppl. 42 (2002) 46-53
6. Skoumas I., Masoura C., Pitsavos C., et al. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia. Int J Cardiol 121 (2007) 178-183
7. Eaton C. Traditional and emerging risk factors for cardiovascular disease. Prim Care 32 (2005) 963-976
8. Williams C.M. Lipid metabolism in women. Proc Nutr Soc 63 (2004) 153-160
9. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2 003;26 (Suppl 1): S21-24.
10. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (2001). Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
11. Aguilar Salinas C., Zamora M., Gomez-Di{dotless}az R., et al. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis. Semin Vasc Med 2 (2004) 203-209
12. Gaddi A., Galetti C., Pauciullo P., and Arca M. Familial combined hyperlipoproteinemia: experts' panel position on diagnostic criteria for clinical practice. Committee of experts of the Atherosclerosis and Dysmetabolic Disorders, Study Group. Nutr Metab Cardiovasc Dis 9 (1999) 304-311
13. Assmann G., and Schulte H. Relation of HDL-cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience): Prospective Cardiovascular Munster Study. Am J Cardiol 70 (1992) 733-737
14. de Graaf J., van der Vleuten G., and Stalenhoef A. Diagnostic criteria in relation to the pathogenesis of familial combined hyperlipidemia. Semin Vasc Med 4 (2004) 229-240
15. Skoumas J., Papadimitriou L., Pitsavos C., et al. Metabolic syndrome prevalence and characteristics in Greek adults with familial combined hyperlipidemia. Metabolism 56 (2007) 135-141
16. Sniderman A., Bailey S., and Engert J. Familial combined hyperlipidemia: how can genetic disorders be common, complex, and comprehensible?. Clin Sci (Lond) 113 (2007) 365-367
17. Pitsavos C., Panagiotakos D., Chrysohoou C., and Stefanadis C. Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study. BMC Public Health 3 (2003) 32-41
18. Kaaja R., and Poyhonen-Alho M. Insulin resistance and sympathetic overactivity in women. J Hypertens 24 (2006) 131-141
19. Williams R., Hunt S., Hopkins P., et al. Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 259 (1988) 333-344
20. Le N., Brown W., Davis W., et al. Comparison of the relation of triglyceride-rich lipoproteins and muscular artery compliance in healthy women versus healthy men. Am J Cardiol 95 (2005) 1049-1054
21. Pilote L., Dasgupta K., Guru V., et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 176 Suppl. (2007) 1-44
22. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) e85-e151
23. Kapoor D., Malkin C., Channer K., and Jones T. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) 63 (2005) 239-250
24. Smith G., Ben-Shlomo Y., Beswick A., et al. Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation 112 (2005) 332-340
25. Juo S., Bredie S., Kiemeney L., Demacker P., and Stalenhoef A. A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia. Am J Hum Genet 63 (1998) 586-594
26. Carr M., and Brunzell J. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 89 (2004) 2601-2607
27. Rigal M., Ruidavets J., Viguier A., et al. Lipoprotein(a) and risk of ischemic stroke in young adults. J Neurol Sci 252 (2007) 39-44
28. Marcucci R., Sofi F., Fedi S., et al. Thrombophilic risk factors in patients with severe carotid atherosclerosis. J Thromb Haemost 3 (2005) 502-507
29. Ohira T., Schreiner P., Morrisett J., et al. Lipoprotein(a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 37 (2006) 1407-1412
30. Cantin B., Despres J., Lamarche B., et al. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study). Am J Cardiol 89 (2002) 662-666
31. Gregg E., Gu Q., Cheng Y., Narayan K., and Cowie C. Mortality trends in men and women with diabetes, 1971-2000. Ann Intern Med 147 (2007) 149-155
32. Natarajan S., Liao Y., Cao G., Lipsitz S., and McGee D. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 163 (2003) 1735-1740
33. Bass K., Newschaffer C., Klag M., and Bush T. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 153 (1993) 2209-2216